Drug Lawsuits

Studies Indicate Uloric Creates Higher Risk of Mortality than Competing Gout Drugs

The FDA first approved gout medication Uloric (febuxostat) in 2009, but under one condition: the manufacturer, Takeda, had to agree to conduct a large postmarket safety clinical trial. The FDA was concerned about possible cardiovascular events with the drug and included a warning about the risk. Takeda agreed to the clinical trial, which was conducted… read more

TDF Drug Side Effects: Who Can File a Lawsuit?

At the heart of the TDF lawsuits filed against Gilead Pharmaceuticals is whether the manufacturer failed to properly warn doctors and patients of the HIV drug’s dangerous side-effects, and whether it withheld a less toxic alternative from the market in order to maximize profits. Those who took Gilead’s TDF-based HIV drugs like Viread and Truvada… read more

Study Halted When Xarelto Shown to Cause More Bleeding Than Aspirin

Researchers have stopped a study on Xarelto’s (rivaroxaban) safety and efficacy early due to “futility,” according to a press release from pharmaceutical manufacturers Bayer and Janssen Research & Development LLC. The Phase III NAVIGATE ESUS study compared Xarelto and aspirin in patients who had recently had an embolic stroke. Both medications are prescribed to help… read more

Studies Reveal New Risks Associated with Blood-Thinners Like Xarelto and Eliquis

According to a recent study published in the Journal of the American Medical Association (JAMA), blood-thinning medications like Xarelto and Eliquis may increase the risk of hematuria-related complications. Hematuria occurs when blood is found in the urine, and related complications may include emergency department visits, hospitalizations, and urologic procedures. Plaintiffs have filed thousands of lawsuits… read more

Study Suggests Some RA Patients at Increased Risk for Actemra Infections

A new study published in the scientific journal Rheumatology indicates that certain patients with rheumatoid arthritis (RA) who take Actemra (tocilizumab) to treat their symptoms may be at an increased risk for dangerous infections than others. Actemra, manufactured by Roche and subsidiary Genentech, is a drug that works by inhibiting parts of the immune system… read more

Study Compares Heart Attack Risk of Testosterone Gels, Patches, and Injections

All federal testosterone replacement lawsuits were consolidated into one court in the Northern District of Illinois in June 2014. However, new research calls into question whether testosterone drugs are all the same. A recent study examined patches, gels, and injections to answer that question. Is there one type of testosterone treatment that is any more… read more